Dofetilide in patients with congestive heart failure and left ventricular dysfunction;Dofetilid til patienter med hjerteinsufficiens og darligt fungerende venstre ventrikel

Ugeskrift for Laeger

Volumn 162, Issue 44, 2000, Pages 5948-5953

  Torp Pedersen, C T ^a   Moller, M ^a   Bloch Thomsen, P E ^a   Kober, L ^a   Sandoe, E ^a   Egstrup, K ^a   Agner, E ^a   Carlsen, J E ^a   Videboek, J ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; DOFETILIDE;

ADULT; AGED; ARTICLE; CONGESTIVE HEART FAILURE; DENMARK; FEMALE; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART VENTRICLE WALL MOTION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; SINUS RHYTHM; TREATMENT OUTCOME;

ADULT; AGED; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CAUSE OF DEATH; DOUBLE-BLIND METHOD; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; PHENETHYLAMINES; SULFONAMIDES; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0034735491     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators
2. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardio-version. A meta-analysis of randomized control trials
3. Randomized trial of low dose amiodarone in severe congestive heart failure
4. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure
5. A Randomized, double-blind, placebo-controlled comparison of intravenous dofetilide and procainamide in the acute conversion of atrial fibrillation/flutter
6. Efficacy and safety of oral dofetilide in maintaining normal sinus rhythm in patients with atrial fibrillation/ flutter: A multicenter study
7. Conversion of atrial fibrillation and maintenance of Sinus rhythm by dofetilide. The EMERALD (European and Australian Multicenter Evaluative Research on Atrial Fibrillation Dofetilide) study
8. Dofetilide in patients with left ventricular dysfunction and either heart failure or acute myocardial infarction: Rationale, design and patient characteristics of the DIAMOND studies
9. An echocardiographic method for selecting high risk patients Shortly after acute myocardial infarction, for inclusion in multi-centre studies (as used in the TRACE Study)
10. Classification of deaths after myocardial infarction ad arrhythmic or nonarrhythmic (the cardiac arrhythmia pilot study)
11. Prediction of creatinine clearance from serum creatinine
12. Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: Observations from the veterans affairs congestive heart failure survival trial of antiarrhythmic therapy (CHF-STAT). The Department of Veterans Affairs CHF-STAT Investigators
13. Mortality and morbidity in patients receiving encainide, flecainide or placebo. The Cardiac Arrhythmia Suppression Trial
14. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction
15. Effect of amiodarone therapy on mortality in patients with left ventricular dysfunction and asymptomatic complex ventricular arrhythmias: Argentine Pilot Study of Sudden Death and Amiodarone (EPAMSA)
16. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators
17. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators
18. A clinical trial of the angiotensin converting enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction